4//SEC Filing
Virnich Daniel 4
Accession 0001799191-24-000043
CIK 0001799191other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 6:23 PM ET
Size
6.9 KB
Accession
0001799191-24-000043
Insider Transaction Report
Form 4
Virnich Daniel
Chief Executive Officer
Transactions
- Disposition to Issuer
Common stock
2024-11-20$0.14/sh−4,977$677→ 711,984 total - Disposition to Issuer
Common stock
2024-11-20$0.14/sh−4,750$646→ 716,961 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.
- [F2]Price is the volume weighted average selling price of all sales by the Reporting Person on November 20, 2024 within a one-dollar range. Actual prices ranged from $0.136 to $0.168. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
Documents
Issuer
Oncology Institute, Inc.
CIK 0001799191
Entity typeother
Related Parties
1- filerCIK 0001891107
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 6:23 PM ET
- Size
- 6.9 KB